01-01-1970 12:00 AM | Source: Accord Fintech
Supriya Lifescience lists with 55.11% premium on the BSE
Supriya Lifescience has debuted at Rs 425.00 on the BSE, up by 151 points or 55.11% from its issue price of Rs 274.
The scrip is currently trading at Rs 396.90, up by 122.90 points or 44.85% from its issue price. It has touched a high and low of Rs 425.00 and Rs 388.20 respectively. So far 5.67 lakh shares were traded on the counter.
The offering, which was open for subscription between December 16, 2021 and December 20, 2021, was subscribed 71.51 times. The issue price was fixed at Rs 274 per share i.e. at upper end of price band of Rs 265-274 apiece.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.
Latest News
Buy Gold Above 71300 SL. Below 71100 TGT 71600/71800...
Market Wrap Up : Technically, after a gap up opening...
State-run banks weigh on India's blue-chip Nifty 50 ...
Marico posts 5.3 pc rise in q4 net profit, declares ...
Evening Roundup : A Daily Report on Bullion Energy &...
Post market comment by Mr Shrey Jain, Founder and C...
Post market comment by Deven Mehata,Choice Broking
Daily Market Analysis :Nifty quickly gave up its gai...
FIIs stood as net sellers in equities as per May 06 ...
India, Ghana agree to operationalise UPI link within...